PTEN c.854A>T ;(p.E285V)

Variant ID: 10-89720703-A-T

NM_000314.4(PTEN):c.854A>T;(p.E285V)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion.

Thoracic Cancer
Zu, Lingling L; Li, Xuebing X; He, Jinling J; Zhou, Ning N; Meng, Fanrong F; Li, Xiaozhou X; Xu, Song S; Zhang, Lei L
Publication Date: 2022-04

Variant appearance in text: PTEN: E285V
PubMed Link: 35297208
Variant Present in the following documents:
  • TCA-13-1199.pdf
View BVdb publication page



Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.

Oncotarget
Xiu, Joanne J; Piccioni, David D; Juarez, Tiffany T; Pingle, Sandeep C SC; Hu, Jethro J; Rudnick, Jeremy J; Fink, Karen K; Spetzler, David B DB; Maney, Todd T; Ghazalpour, Anatole A; Bender, Ryan R; Gatalica, Zoran Z; Reddy, Sandeep S; Sanai, Nader N; Idbaih, Ahmed A; Glantz, Michael M; Kesari, Santosh S
Publication Date: 2016-04-19

Variant appearance in text: PTEN: E285V
PubMed Link: 26933808
Variant Present in the following documents:
  • oncotarget-07-21556-s001.pdf
View BVdb publication page



Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status.

Oncotarget
Xiao, Zhiguang Z; Sperl, Bianca B; Ullrich, Axel A; Knyazev, Pjotr P
Publication Date: 2014-12-30

Variant appearance in text: PTEN: E285V
PubMed Link: 25375092
Variant Present in the following documents:
  • Main text
  • oncotarget-05-12877.pdf
View BVdb publication page